Pediculosis Treatment Market: By Louse Type (Pediculosis Capitis, Pediculosis Pubis, and Pediculosis Corporis), By Treatment (Dimeticone Lotion, Isopropyl Alcohol), & By Region-Forecast (2016-2021)

  • ID: 3974068
  • Report
  • Region: Global
  • 159 pages
  • IndustryARC
1 of 4


  • Bayer AG (Germany)
  • Lavipharm (Greece)
  • ParaPRO LLC (U.S.)
  • TyraTech Inc. (U.S.)
  • MORE
Pediculosis is caused due to infestation of blood feeding Phthiraptera, and an ectoparasitic insect Louse. Lice saliva enters human circulatory system, while sucking human blood and this causes puritus. Pediculosis spreads through close physical contact, cloths and linens, combs, hats, and others. Globally, increase in prevalence of pediculosis, rise in the awareness regarding pediculosis, and growing adoption of human lice in forensic studies are the prime growth drivers of global pediculosis treatment market. In addition, increase in adoption of pediculosis treatment in emerging economies such as China, India and others, will create new opportunities for global pediculosis treatment market. However, higher cost of the research and development, and lack of diagnostic tools and condition specific treatment are the key restraints for global pediculosis treatment market.

This report identifies the global pediculosis treatment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global pediculosis treatment market.

Geographically North America dominated global pediculosis treatment market due to modernize healthcare infrastructure, higher healthcare spending, reimbursement coverage and government support. Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, rise in awareness about pediculosis and related treatments, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the louse type, pediculosis pubis has the highest market share in global pediculosis treatment market.

This report segments global pediculosis treatment market on the basis of louse type, treatment, and regional market as follows:

Pediculosis Treatment Market, By Louse Type: Pediculosis Capitis, Pediculosis Pubis, and Pediculosis Corporis
The report has focused study on pediculosis treatment market by basis of treatment such as: Dimeticone Lotion, Malathion + Dimeticone Lotion, Isopropyl Alcohol, Suffocation-Based Pediculicide, Petrolatum, Mercuric Oxide Ointment, and Others

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the pediculosis treatment market. Some of the major companies’ profiles in detail are as follows:

Clearwater Paper Corporation
DS Smith PLC
Packaging Corp. of America
Amcor Limited
Cascades Inc.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 4


  • Bayer AG (Germany)
  • Lavipharm (Greece)
  • ParaPRO LLC (U.S.)
  • TyraTech Inc. (U.S.)
  • MORE
1. Pediculosis Treatment Market Overview

2. Pediculosis Treatment Market- Executive Summary

3. Pediculosis Treatment Market Landscape
3.1. Market Share Analysis
3.2. Competitive analysis
3.2.1. Product Benchmarking
3.2.2. End-User Profiling
3.2.3. Patent analysis
3.2.4. Top 5 Financials Analysis

4. Pediculosis Treatment Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Global Pediculosis Treatment Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition

5. Pediculosis Treatment Market- Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product/Market Life Cycle
5.5. Suppliers and Distributors

6. Pediculosis Treatment Market - By Louse Type
6.1. Introduction
6.2. Pediculosis Capitis
6.3. Pediculosis Pubis
6.4. Pediculosis Corporis

7. Pediculosis Treatment Market - By Treatment
7.1. Introduction
7.2. Dimeticone Lotion
7.3. Malathion + Dimeticone Lotion
7.4. Isopropyl Alcohol
7.5. Suffocation-Based Pediculicide
7.6. Petrolatum
7.7. Mercuric Oxide Ointment
7.8. Others

8. Pediculosis Treatment Market- By Geography
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Rest of Europe
8.4. APAC
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. South Korea
8.4.5. Rest of APAC
8.5. RoW
8.5.1. Middle East
8.5.2. Africa
8.5.3. South America

9. Pediculosis Treatment Market Entropy

10. Pediculosis Treatment Market - Company Profiles
10.1. TyraTech Inc. (U.S.)
10.2. Tec Laboratories Inc. (U.S.)
10.3. Arbor Pharmaceuticals LLC (U.S.)
10.4. Logic Product Group (U.S.)
10.5. Major Pharmaceuticals (U.S.)
10.6. ParaPRO LLC (U.S.)
10.7. Prestige Brands, Inc. (U.S.)
10.8. Bayer AG (Germany)
10.9. Thornton & Ross Limited (U.K.)
10.10. Lavipharm (Greece)

11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation of Expert Insights
11.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • Arbor Pharmaceuticals LLC (U.S.)
  • Bayer AG (Germany)
  • Lavipharm (Greece)
  • Logic Product Group (U.S.)
  • Major Pharmaceuticals (U.S.)
  • ParaPRO LLC (U.S.)
  • Prestige Brands, Inc. (U.S.)
  • Tec Laboratories Inc. (U.S.)
  • Thornton & Ross Limited (U.K.)
  • TyraTech Inc. (U.S.)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown